Big pharma failing to develop urgent drugs for poorest countries

Julia Kollewe of the Guardian covers the latest Access to Medicine Index: "most firms focus on infectious diseases such as HIV/AIDS, malaria and tuberculosis but had failed to focus on other serious ailments." Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation, is quoted as saying: "There have been massive improvements in global health in the past decades, with all major pharmaceutical companies taking action. To close the gaps that remain, a greater diversity of companies must get involved and stay engaged for the long haul."